Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Sanofi encounters resistance, lowers price for cancer drug
Sanofi announced it would offer a 50% discount to doctors and hospitals on cancer drug Zaltrap after three doctors from Memorial Sloan-Kettering Cancer Center publicized the health system's refusal to prescribe the drug because it was too expensive and no more effective than similar drugs. Medicare reimbursement and patient co-payments will be based on the higher list price in the short term.
Or we can send an email on your behalf